Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022

BUY
$1.42 - $3.15 $1,065 - $2,362
750 New
750 $1,000
Q1 2022

Apr 29, 2022

SELL
$2.65 - $5.08 $1,987 - $3,810
-750 Closed
0 $0
Q3 2021

Oct 21, 2021

BUY
$5.16 - $7.98 $3,870 - $5,985
750 New
750 $6,000
Q2 2021

Jul 26, 2021

SELL
$6.45 - $9.09 $4,837 - $6,817
-750 Closed
0 $0
Q1 2021

May 05, 2021

BUY
$7.25 - $13.82 $5,437 - $10,365
750 New
750 $6,000

Others Institutions Holding SURF

About Surface Oncology, Inc.


  • Ticker SURF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,034,000
  • Description
  • Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...
More about SURF
Track This Portfolio

Track Total Clarity Wealth Management, Inc. Portfolio

Follow Total Clarity Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.